by Site Strategics | Mar 2, 2020 | News
In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA...
by MiraVista Admin | Feb 22, 2016 | Announcement Archive, News
MiraVista Diagnostics is adding several new positions across all departments to meet growing market demand for its mycology diagnostic testing services. The scientific company is actively recruiting qualified candidates for research, medical laboratory, sales and...